The philanthropic organization founded by Roblox CEO David Baszucki and his wife, Jan Ellison Baszucki, announced a $20 million grant on October 21, 2026, to establish the McLean Center for Metabolic Psychiatry at McLean Hospital in Belmont, Massachusetts. Inspired by their son's experience with bipolar disorder, the funding will support clinical care, medical education, and scientific research into how nutrition and metabolic processes affect severe psychiatric conditions.

The grant from the Baszucki Group also anchors the launch of the Global Network for the Advancement of Metabolic Psychiatry, known as MetPsy, according to The Boston Globe. Leaders at McLean Hospital, a psychiatric institution within the Mass General Brigham health system, stated that the new facility will be the first center of its kind in the United States dedicated to evaluating metabolic therapies for mental health.

A Personal Catalyst for Institutional Research

The financial commitment stems from the Baszucki family's search for effective care for their now 30-year-old son, Matthew Baszucki, who was diagnosed with bipolar disorder. According to WBUR, the family publicly detailed how their son experienced multiple psychiatric hospitalizations, consulted dozens of healthcare providers, and was prescribed more than a dozen different medications. At one point during his illness, he left home in a psychotic state and lived on the streets of Los Angeles.

Jan Ellison Baszucki eventually contacted Dr. Christopher Palmer, a Harvard psychiatrist, after hearing him discuss ketogenic dietary therapy for bipolar disorder on a podcast. Five years ago, Palmer agreed to consult with the family. Under medical supervision, Matthew Baszucki adopted a clinical version of the ketogenic diet—a nutritional regimen high in fat and very low in carbohydrates that has been used by physicians for decades to manage medication-resistant epilepsy.

Speaking on the family-founded Metabolic Mind podcast in June, Matthew Baszucki reported that his symptoms improved after roughly four months on the diet, noting that his sleep stabilized and his episodes of mania and delusion ceased. "My brain felt like it could work again," he said on the podcast, adding that he was able to begin gradually tapering his medications under clinical guidance.

The Science of Metabolic Psychiatry

While the Baszucki family's philanthropic outreach was sparked by an individual recovery, clinicians emphasize that metabolic psychiatry remains an emerging field that requires rigorous institutional study. The discipline focuses on the intersection of the body's energy production and psychiatric disorders such as bipolar disorder, severe depression, and schizophrenia.

Dr. Dost Öngür, chief of the psychotic disorders division at McLean Hospital and director of the new center, explained in an interview with The Boston Globe that the brain is the body's most energy-demanding organ, gram for gram. Over the past decade, scientific studies have identified abnormalities in how the brain produces and utilizes energy in individuals with severe mental illnesses.

"This has led to a growing awareness that metabolic processes are important for healthy brain function, and when they become abnormal they might contribute to the emergence of psychiatric disorders," Öngür said. He added that investigating how to correct these metabolic abnormalities offers a potential path toward improving symptoms for patients living with complex psychiatric conditions.

There is a notable distinction between personal accounts and established clinical consensus. While WBUR highlights that a version of the ketogenic diet proved effective for Matthew Baszucki, The Boston Globe characterizes ketogenic therapy as a developing area of investigation. Öngür noted that establishing the clinic within a major medical institution will allow researchers to systematically gather data on which metabolic approaches work, which do not, and how dietary therapies interact with standard psychiatric medications.

How the $20 Million Grant Will Be Used

The $20 million commitment is structured to build clinical capacity, research infrastructure, and professional training rather than serve as an endorsement of diet as a standalone cure. While some secondary coverage frames the donation primarily around ketogenic diets, institutional reporting from Becker's Behavioral Health and WBUR confirms the scope encompasses broader metabolic psychiatry research, clinical care, and medical education, alongside a specialized focus on ketogenic interventions.

In addition to supporting direct clinical services and research trials at McLean Hospital, the grant funds educational initiatives co-led with MH², a clinical practice, training, and education hub, as well as the broader MetPsy network to connect clinicians and scientists globally.

How is the $20 million divided among research, care, and training?

The public grant announcement from the Baszucki Group and McLean Hospital does not specify a line-item budget or exact financial breakdown among direct patient services, clinical trials, research staffing, and medical training initiatives.

What does this mean for patients with bipolar disorder?

For patients and families navigating bipolar disorder or schizophrenia, the creation of the McLean Center for Metabolic Psychiatry represents an expansion of clinical trials and supervised care options within an academic medical setting. However, psychiatric specialists caution that restrictive metabolic diets alter body chemistry and can interact with prescribed medications. Patients considering nutritional or metabolic therapies for mental health conditions should only do so under the direct supervision of a qualified medical team rather than attempting to alter their diet or medication regimens independently.